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silence Nrf2 expression. SFN signiﬁcantly up-regulated Nrf2 and also prevented Ang
II-induced CTGF and PAI-1expression, which were completely abolished by Nrf2
silence. Furthermore, Nrf2-TG mice were highly resistant to Ang II-induced cardiac
pathogenic changes and cardiac dysfunction. To dissect the mechanism for SFN acti-
vation of Nrf2, H9c2 cells were given SFN (10 mM) simultaneously with and without
Akt inhibitor (LY294002, 10 mM). SFN’s activation of Nrf2 was partially inhibited by
Akt inhibition that also induced GSK-3b activation and Fyn nuclear accumulation.
Conclusions: Ang II-induced cardiomyopathy can be prevented by SFN via Akt/
GSK-3b/Fyn-mediated activation of Nrf2 antioxidant pathway.
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Post-ischemic myocardial insulin resistance induced by TNF-a overproduction
precipitates the development of heart failure after myocardial infarction
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Objectives: Clinical evidence has demonstrated a decreased myocardial insulin
response in heart failure (HF) patients. The objective of this study is to investigate the
role of myocardial insulin resistance in the development of ischemic HF and its un-
derlying mechanisms.
Methods: Adult male Sprague Dawley rats were subjected to a permanent occlusion
of the left anterior descending coronary artery. Cardiac function and remodeling were
evaluated by echocardiographic. Insulin stimulated myocardial ﬂuorodeoxyglucose
(FDG) uptake were measured by micro-PET/CT.
Results: Rats subjected to myocardial infarction (MI) resulted in a progressive left
ventricular (LV) remodeling and dysfunction. Echocardiographic assessment showed
preserved LV end-systolic dimension (LVESD 0.4530.027 cm) and ejection fraction
(EF 57.032.35%) at 1 week after MI, and evident LV dilation (LVESD
0.6210.026 cm) and dysfunction (EF 40.123.09%) at 4 weeks. Myocardial insulin
sensitivity decreased signiﬁcantly at 1 week after MI as evidenced by reduced insulin-
stimulated myocardial ﬂuorodeoxyglucose uptake (Standardized Uptake Value:
2.710.42 vs. 5.130.51 of sham+insulin, n¼6, P<0.01) and GLUT-4 translocation
and altered insulin signaling. Meanwhile, MI increased myocardial TNF-a production.
Treatment with Etanercept (a TNF-a inhibitor) during the ﬁrst week following MI
improved myocardial insulin sensitivity, while adenovirus-mediated cardiac over-
expression of TNF-a resulted in myocardial insulin resistance in non-MI hearts.
In addition, TNF-a overexpressed rat hearts exhibited LV dysfunction
(EF 41.324.21%) and LV dilation (LVESD 0.6270.036 cm) as early as 1 wk after
MI. More importantly, tamoxifen-induced cardiomyocyte-speciﬁc insulin receptor
knockout mice developed aggravated post-ischemic LV remodeling and dysfunction
compared with littermate controls (EF 31.542.41 vs. 45.322.65 %, LVESV
31.542.41 vs. 45.212.65 ml, both P<0.05). Insulin treatment during the ﬁrst week
following MI not only suppressed myocardial TNF-a production and increased
myocardial insulin sensitivity, but also alleviated cardiac dysfunction and remodeling
at 4 wk after MI.
Conclusions: Myocardial insulin resistance induced at least partly by TNF-a over-
production following MI contributes to the development of post-ischemic HF, which
indicates an essential role of myocardial insulin signaling in protection against
ischemic HF.
GW25-e4306
Angiotensin-(1-7) stimulates cholesterol efﬂux from angiotensin II-treated
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Objectives: Angiotensin II (Ang II) and angiotensin-(1-7) (Ang-(1-7) ) are key
effector peptides of the renin-angiotensin system. The aim of this study is to inves-
tigate the effects of Ang-(1-7) on Ang II-stimulated cholesterol efﬂux and associated
molecular mechanisms.
Methods: Differentiated THP-1 macrophages were treated with Ang II (1 mM) and/or
Ang-(1-7) (10 and 100 nM) for 24 h and cholesterol efﬂux and gene expression were
assessed. Pharmacology inhibition of peroxisome proliferator-activated receptor
gamma (PPARg) and mitogen-activated protein kinases (MAPKs) were done to
identify the signaling pathways involved.
Results: Our results showed that Ang II signiﬁcantly inhibited cholesterol efﬂux from
cholesterol-loaded THP-1 macrophages. Ang-(1-7) led to a dose-dependent restoration
of cholesterol efﬂux in Ang II-treated cells. The co-treatment with Ang-(1-7) and Ang
II signiﬁcantly increased the ABCA1 and ABCG1 expression relative to treatment
with Ang II alone, which was coupled with increased expression of PPARg and liver
X receptor alpha (LXRa). Pharmacological inhibition of PPARg signiﬁcantly
(P<0.05) abolished Ang-(1-7) -mediated induction of ABCA1 and ABCG1 mRNA
expression. Ang-(1-7) treatment caused an inactivation of JNK and p38 MAPK
signaling in Ang II-treated THP-1 macrophages. Moreover, inhibition of JNK or p38
MAPK signaling using speciﬁc pharmacological inhibitors mimicked the induction of
PPARg and LXRa expression by Ang-(1-7).
Conclusions: Taken together, our data demonstrate that Ang-(1-7) promotes choles-
terol efﬂux in Ang II-treated THP-1 macrophages in part through inactivation of p38
and JNK signaling and induction of PPARg and LXRa expression and may thus have
therapeutic beneﬁts in atherosclerosis.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e4414
Berberine improves coronary vasodilation and prevents endothelial apoptosis via
activating Akt-eNOS in diabetic rats
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Objectives: The impaired endothelial cells are the major cause of vessel dysfunction
in diabetes. Berberine, an isoquinoline alkaloid, has been demonstrated to lower blood
glucose and regulate lipid metabolism disorders, while the mechanism of protection of
berberine in diabetic cardiovascular disease remains elusive. In present study, we
sought to study the effects of berberine on diabetes coronary artery vessel dysfunction
and the underling mechanisms.
Methods: Diabetic rat were induced by injected streptozotocin and fed with a high-fat
diet for 12 weeks. Rats were randomized to receiving saline or berberine treatments
(200 mg/kg/d, gravage) in the last 4 weeks. HUVECs were cultured in HG/HF
(25 mmol/L glucose DMEM and 500 mmol/L palmitate) to simulate the damage
endothelial dysfunction of diabetes in vitro.
Results: Coronary arteries from berberine treated diabetic rats exhibited an obvious
ACh-induced vasodilatation enhancement. Moreover, berberine treatment improves
the insulin mediated vasodilatation of coronary artery compared with the diabetic rats
(26.6% vs. 3.2%, n¼12, P<0.01). More interestingly, the beneﬁcial effects of
berberine on vasodilatation were blunted by wortmannin, an inhibitor of PI3K/Akt.
According to TUNEL staining, treatment of berberine signiﬁcantly attenuated diabetic
rats coronary artery endothelium apoptosis. In vitro study, berberine treatment reduced
HG/HF-induced HUVECs apoptosis, increased Bcl-2/Bax ratio and decreased cas-
pase-3 expression signiﬁcantly, together with enhanced Akt, GSK3b and eNOS
phosphorylation. While, pretreatment with either wortmannin or AMPK inhibitor
Compound C, the anti-apoptotic effect of berberine were signiﬁcantly blunted.
Conclusions: Berberine enhances vasodilatation and protects against endothelial
apoptosis in diabetes rats coronary artery, which is mainly through the activation of
the Akt-eNOS signaling.
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High levels of circulating endothelial microparticles and increased tissue factor
procoagulant activity of plasma microparticles in patients with acute coronary
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Objectives: Microparticles (MPs) are submicron vesicles released from activated or
apoptotic cells and involved in message delivering. Elevated numbers of platelet
microparticles (PMPs) and endothelial microparticles (EMPs) have been reported in
patients with acute coronary syndrome (ACS). The purpose of this study was to assess
levels and tissue factor procoagulant activity of circulating MPs in patients with ACS.
Methods: AnnexinVpositive MPs (AMPs), PMPs, CD31 positive EMPs, CD62E
positive EMPs, and monocyte MPs (MMPs) were measured in 36 patients with ACS.
We also enrolled 16 healthy individuals as normal controls. Calibrated automated
thrombogram assay was used to evaluate the MP-mediated thrombin generation
among ACS patients and normal controls. The lag time, time to peak, endogenous
thrombin potential (ETP), peak thrombin generation between two groups were
measured and compared. Furthermore, we investigated the association between var-
iables such as numbers of MPs, lag time, endogenous thrombin potential, high-
sensitivity C-reactive protein (hs-CRP), and peak value of cardiac troponin I (TnI).
Results: CD31 positive EMPs with the concentration of 1118 /mL were main circu-
lating MPs in ACS patients. Through thrombin generation test, both the ETP
(924.2349.9 vs 652.3146.7 nMmin, P¼0.001) and the peak (87.539.6 vs
55.024.4 nM, P¼0.002) increased in ACS patients compared with those of healthy.
For ACS patients, the levels of AMPs were negatively correlated with the peak value
of TnI (rp¼ -0.416, P¼0.028), while the levels of CD31 positive EMPs were nega-
tively correlated with high-density lipoprotein cholesterol (HDL-C) (rp¼ -0.493,
P¼0.009).
Conclusions: CD31 positive EMPs were the main circulating MPs presented in ACS
patients. Compared to healthy, tissue factor procoagulant activity of plasma MPs
increased in patients with ACS.
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Objectives: Vascular injury caused by hypertension is a chronic low-grade inﬂam-
mation process, especially a growing number of studies have shown that inﬂammatory
response in vascular adventitial not only involved in hypertension, but also in
atherosclerosis and vascular restenosis. As the important composition of outer
membrane, perivascular adipose tissue (PVAT) secretes a variety of biological active
substances involved in regulation of vascular pathophysiology function. Our previous
study found that PVAT secretes inﬂammatory factors involved in vascular remodeling
in DOCA-salt hypertensive model. And the expression of inﬂammatory factor is
regulated by many factors at the transcription and post-transcription level. MiRNAsasic and Translational Medicine C3
